Why is Jubilant Pharmo falling/rising?

As of 22-Jul, Jubilant Pharmova Ltd is currently priced at 1,205.00, reflecting a decrease of 19.05 or 1.56%. The stock has been underperforming its sector, with a performance today that is down by 0.65%. It has experienced a consecutive fall over the last two days, resulting in a total decline of 2.42%. Despite this recent downturn, the stock has shown strong performance over the longer term, with a 66.25% increase over the past year, and positive results in operating profit growth. However, there are concerns regarding poor long-term growth, as net sales have declined at an annual rate of 0.73% over the last five years, which may be contributing to the recent price drop.
In the broader market context, the stock has outperformed the benchmark Sensex in both the short term and long term, with a 1-week return of 0.66% compared to the Sensex's decline of 0.47%. This indicates that while Jubilant Pharmova has been performing well relative to the market, the recent price decline suggests that investor sentiment may be shifting, possibly due to falling investor participation and concerns about long-term growth prospects. The stock's liquidity remains adequate, but the decrease in delivery volume could signal waning interest among investors, which may further impact its price movement.